Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The protective effect of SARS-COV-2 antibodies in Scottish healthcare workers

Hani Abo-Leyah, Stephanie Gallant, Diane Cassidy, Yan Hui Giam, Justin Killick, Beth Marshall, Gordon Hay, Caroline Snowdon, Eleanor J. Hothersall, Thomas Pembridge, Rachel Strachan, Natalie Gallant, Benjamin J. Parcell, Jacob George, Elizabeth Furrie, James D. Chalmers
ERJ Open Research 2021; DOI: 10.1183/23120541.00080-2021
Hani Abo-Leyah
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Gallant
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Cassidy
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Hui Giam
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Killick
2Department of Immunology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beth Marshall
2Department of Immunology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Hay
2Department of Immunology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Snowdon
3Department of Public Health, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleanor J. Hothersall
3Department of Public Health, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Pembridge
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Strachan
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Gallant
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin J. Parcell
4Department of Microbiology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob George
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Furrie
2Department of Immunology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK
5Contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Chalmers
1Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK
5Contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.chalmers@dundee.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background Healthcare workers (HCW) are believed to be at increased risk of SARS-CoV-2 infection. It is not known to what extent the natural production of antibodies to SARS-CoV-2 is protective against re-infection.

Methods A prospective observational study of HCW's in Scotland (UK) from May to September 2020. The Siemens SARS-CoV-2 total antibody assay was used to establish seroprevalence in this cohort. Controls, matched for age and sex to the general local population, were studied for comparison. New infections (up to 2/12/2020) post antibody testing were recorded to determine if the presence of SARS-CoV-2 antibodies protect against re-infection.

Results A total of 2063 health and social care workers were recruited for this study. At enrolment 300 HCW had a positive antibody test (14.5%). 11/231 control sera tested positive (4.8%). HCW therefore had an increased likelihood of a positive test (Odds ratio 3.4 95% CI 1.85–6.16, p<0.0001). Dentists were most likely to test positive. 97.3% of patients who had previously tested positive for SARS-CoV-2 by RT-PCR had positive antibodies. 18.7% had an asymptomatic infection. There were 38 new infections with SARS-CoV-2 in HCW who were previously antibody negative and one symptomatic RT-PCR positive re-infection. The presence of antibodies was therefore associated with an 85% reduced risk of re-infection with SARS-CoV-2 (HR 0.15, 95% CI 0.06 to 0.35, p=0.026).

Conclusion HCW were three times more likely to test positive for SARS-CoV-2 than the general population. Almost all infected individuals developed an antibody response which was 85% effective in protecting against re-infection with SARS-CoV-2.

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Abo-Leyah has nothing to disclose.

Conflict of interest: Stephanie Gallant has nothing to disclose.

Conflict of interest: Diane Cassidy has nothing to disclose.

Conflict of interest: Ms. Giam has nothing to disclose.

Conflict of interest: Mr. Killick has nothing to disclose.

Conflict of interest: Beth Marshall has nothing to disclose.

Conflict of interest: Mr. Hay has nothing to disclose.

Conflict of interest: Dr. Snowdon has nothing to disclose.

Conflict of interest: Dr. Snowdon has nothing to disclose.

Conflict of interest: Mr. Pembridge has nothing to disclose.

Conflict of interest: Ms. Strachan has nothing to disclose.

Conflict of interest: Ms. Gallant has nothing to disclose.

Conflict of interest: Dr. Parcell has nothing to disclose.

Conflict of interest: Dr. Parcell has nothing to disclose.

Conflict of interest: Dr. Furrie has nothing to disclose.

Conflict of interest: Dr. Chalmers reports grants and personal fees from astrazeneca, grants and personal fees from boehringer ingelheim, personal fees from chiesi, grants and personal fees from glaxosmithkline, grants from gilead sciences, grants and personal fees from insmed, personal fees from novartis, personal fees from zambon, outside the submitted work.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received January 30, 2021.
  • Accepted April 8, 2021.
  • Copyright ©The authors 2021
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 9 Issue 2 Table of Contents
ERJ Open Research: 9 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The protective effect of SARS-COV-2 antibodies in Scottish healthcare workers
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The protective effect of SARS-COV-2 antibodies in Scottish healthcare workers
Hani Abo-Leyah, Stephanie Gallant, Diane Cassidy, Yan Hui Giam, Justin Killick, Beth Marshall, Gordon Hay, Caroline Snowdon, Eleanor J. Hothersall, Thomas Pembridge, Rachel Strachan, Natalie Gallant, Benjamin J. Parcell, Jacob George, Elizabeth Furrie, James D. Chalmers
ERJ Open Research Jan 2021, 00080-2021; DOI: 10.1183/23120541.00080-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The protective effect of SARS-COV-2 antibodies in Scottish healthcare workers
Hani Abo-Leyah, Stephanie Gallant, Diane Cassidy, Yan Hui Giam, Justin Killick, Beth Marshall, Gordon Hay, Caroline Snowdon, Eleanor J. Hothersall, Thomas Pembridge, Rachel Strachan, Natalie Gallant, Benjamin J. Parcell, Jacob George, Elizabeth Furrie, James D. Chalmers
ERJ Open Research Jan 2021, 00080-2021; DOI: 10.1183/23120541.00080-2021
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Microbial and host immune factors as drivers of COPD
  • Asymmetry in acute exacerbation of IPF
  • Multiple large clusters of tuberculosis in London
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society